Provided by Tiger Trade Technology Pte. Ltd.

Kura Oncology

12.40
+0.51004.29%
Post-market: 13.170.7729+6.23%19:59 EDT
Volume:2.70M
Turnover:33.56M
Market Cap:1.10B
PE:-3.68
High:12.87
Open:11.77
Low:11.43
Close:11.89
52wk High:12.90
52wk Low:7.36
Shares:88.77M
Float Shares:70.60M
Volume Ratio:0.93
T/O Rate:3.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3668
EPS(LYR):-3.1784
ROE:-167.71%
ROA:-31.30%
PB:22.73
PE(LYR):-3.90

Loading ...

Kura Oncology CEO Troy Wilson Acquires 100,000 Common Shares Valued at $1,239,000

Reuters
·
3 hours ago

Kura Oncology CEO buys $1.24M in common stock

TIPRANKS
·
1 hour ago

Kura Oncology Chief Commercial Officer Brian T. Powl Sells 4,345 Common Shares for USD 51,656.85

Reuters
·
3 hours ago

Kura Oncology Price Target Maintained with a $24.00/Share by Citizens

Dow Jones
·
Yesterday

UBS Remains a Buy on Kura Oncology (KURA)

TIPRANKS
·
Aug 21

Kura Oncology Currently up Nine Days Straight, on Track for Record Winning Streak

Dow Jones
·
Aug 18

Kura Oncology CEO buys $1.11M in common stock

TIPRANKS
·
Aug 18

Kura Oncology CEO Troy Wilson Reports Purchase of 100,000 Common Shares Worth $1.11 Million

Reuters
·
Aug 18

Celcuity Posts Narrower-than-Expected Loss as R&D Costs Decreased

Reuters
·
Aug 14

Kura Jumps on Narrower-than-Expected Quarterly Loss

Reuters
·
Aug 13

Phil Nadeau Reiterates Buy on Kura Oncology as Komzifti Outperforms Expectations and Pipeline Progress Strengthens Long-Term Outlook

TIPRANKS
·
Aug 13

Kura Oncology Price Target Raised to $38.00/Share from $36.00 by Wedbush

Dow Jones
·
Aug 13

Karyopharm Q2 Revenue Falls as License Revenue Drops; Expects Funds to Last into September

Reuters
·
Aug 13

Wedbush Adjusts Price Target on Kura Oncology to $38 From $36, Keeps Outperform Rating

MT Newswires Live
·
Aug 13

Barclays Reaffirms Their Buy Rating on Kura Oncology (KURA)

TIPRANKS
·
Aug 13

Sweden's RaySearch Q2 Order Intake Rises on Clinical Adoption

Reuters
·
Aug 13

Kura Oncology, Inc. : Leerink Partners Raises Target Price to $28 from $21

THOMSON REUTERS
·
Aug 13

Kura Oncology Posts Corporate Presentation on Komzifti Launch, Ziftomenib Pipeline Strategy

Reuters
·
Aug 13

Kura Oncology, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Earnings Flash (KURA) Kura Oncology Posts Q2 Loss Per Share $0.77, vs. FactSet Est of Loss $0.88

MT Newswires Live
·
Aug 13